ArticleFrontiers in genetics2022

Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma.

Sibin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.